Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

This new study featured the results from the STEP 9 phase 3 clinical trial conducted by healthcare company Novo Nordisk aimed ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

In Louisiana and across the country, pancreatic cancer continues to be one of the most aggressive and deadly forms of the ...

Subcutaneous semaglutide is currently marketed under the brand name Wegovy for chronic weight management and to reduce the risk of major adverse cardiovascular events in adults with established ...

The Chancellor presented her budget to Parliament on Wednesday 30th October. Here are our initial thoughts on how this Budget ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

A Race Against Blindness, a nonprofit organization dedicated to funding sight-saving research for children, is pleased to announce a $1 million grant to Axovia ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...